Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

203.34
+0.24000.12%
Post-market: 203.00-0.3400-0.17%19:45 EDT
Volume:1.48M
Turnover:301.21M
Market Cap:10.45B
PE:32.22
High:205.81
Open:201.84
Low:201.12
Close:203.10
52wk High:217.12
52wk Low:149.09
Shares:51.40M
Float Shares:51.40M
Volume Ratio:0.77
T/O Rate:2.87%
Dividend:0.35
Dividend Rate:0.17%
EPS(TTM):6.31
EPS(LYR):35.34
ROE:24.54%
ROA:0.10%
PB:1.28
PE(LYR):5.75

Loading ...

Cognizant, Gilead Sign 5-Year Tech Extension Covering DevOps, AI Tools

MT Newswires Live
·
Oct 06

Cognizant announces five-year extension of its work with Gilead Sciences

TIPRANKS
·
Oct 06

Sector Update: Healthcare

MT Newswires Live
·
Oct 06

Cognizant - to Support Gilead's Devops and AI Tools Across Selected Technology Programs

THOMSON REUTERS
·
Oct 06

Cognizant Expands AI-Enabled Devops Capabilities for Gilead Sciences

THOMSON REUTERS
·
Oct 06

Entera Bio Appoints Ex-Gilead Executive Laura Hamill to Board of Directors

Reuters
·
Oct 06

Regeneron Pharmaceuticals - Sanofi Enter Sixth Amendment to License and Collaboration Agreement - SEC Filing

THOMSON REUTERS
·
Oct 06

Regeneron Pharmaceuticals - Ipr&D Charge Expected to Reduce Q3 2026 Gaap and Non-Gaap EPS by $0.18 - SEC Filing

THOMSON REUTERS
·
Oct 06

Regeneron to Present Phase 3 C-POST Overall Survival Update for Adjuvant Libtayo in High-Risk CSCC at ESMO 2026

Reuters
·
Oct 06

Sanofi Can Move Forward to Pursue Deals

Dow Jones
·
Oct 06

Moderna Inc. Stock Rises 6.9%, Outperforms Peers

Dow Jones
·
Oct 06

Sector Update: Healthcare Stocks Rise Monday Afternoon

MT Newswires Live
·
Oct 06

Exchange-Traded Funds Rise, US Equities Higher After Midday

MT Newswires Live
·
Oct 06

Vortex Energy Launches Study on Natural Hydrogen and Helium at Robinsons River Salt Project

TIPRANKS
·
Oct 06

Exchange-Traded Funds, Equity Futures Down Pre-Bell Monday as Tech Stocks Normalize

MT Newswires Live
·
Oct 05

Sector Update: Healthcare

MT Newswires Live
·
Oct 05

Nurix, Gilead Extend Research Term for Oncology Program by Two Years for $10 Million Fee

Reuters
·
Oct 05

Nurix Extends Gilead Collaboration for Oncology Program

Reuters
·
Oct 05

Nurix - Eligible for up to $1.30 Bln in Total Payments as of May 31, 2026

THOMSON REUTERS
·
Oct 05

Nurix - Eligible for Mid-Single-Digit to Low-Teens Percentage Tiered Royalties

THOMSON REUTERS
·
Oct 05